Floatz logo

Pregabalin

Spinal Cord Diseases

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Small moleculePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Spinal Cord Diseases cohort.

Asset / SponsorPhaseRating
Oxybutynin
Astellas Pharma Inc
Phase 4BB
Marijuana
Barth Wilsey
Phase 2/3B
SOLIFENACIN
Astellas Pharma Inc
Phase 4B
TAURURSODIOL
Amylyx Pharmaceuticals Inc.
Phase 2B

Same molecule, other indications

Pregabalin is also rated in:

neuralgiaDormant
A
Indicative ·
82 / 100
View asset →
peripheral neuropathyDormant
A
Indicative ·
82 / 100
View asset →
focal epilepsyDormant
A
Indicative ·
82 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →